Blick auf eine wehende amerikanische Flagge in der Innenstadt von New York.
Quelle: - ©unsplash.com:
Google
PR Newswire  | 

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Alert: Schubert Jonckheer Investigates Possible False Statements and Insider Trading

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
GeneDx Holdings Corp 158,96 $ GeneDx Holdings Corp Chart -1,85%
Zugehörige Wertpapiere:

SAN FRANCISCO, July 21, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises GeneDx Holdings Corp. (NASDAQ: WGS) investors that the firm is investigating potential legal claims relating to alleged false statements about its health intelligence platform called Centrellis. Current shareholders are encouraged to contact the firm.

INVESTOR ALERT: GeneDx Holdings Corp. (NASDAQ: WGS). If you own stock in GeneDx, you may have legal options.

On June 23, 2025, Judge Vernon D. Oliver of the U.S. District Court for the District of Connecticut ruled that a securities fraud lawsuit against GeneDx, its CEO, and former company executives could move forward. The lawsuit alleges that between January 2022 and August 2022, GeneDx (then named Sema4 Holdings Corp.) misled investors by falsely overstating the capabilities, potential, and commercial viability of Centrellis. These statements allegedly caused GeneDx's stock to trade at artificially inflated prices. Judge Oliver found that the complaint sufficiently alleged that the defendants made false and misleading statements regarding Centrellis with an intent to defraud. During this period, various company insiders sold significant amounts of GeneDx stock. After the truth came out in August 2022 that GeneDx was significantly shifting its core R&D strategy and business model, its President was resigning, and the company was cutting 13% of its workforce, GeneDx's stock price fell 33%.

We are investigating potential wrongdoing by GeneDx's directors and officers in connection with these allegations.

If you own stock in GeneDx, you may have legal options. Visit https://www.classactionlawyers.com/genedxto learn more.

About Schubert Jonckheer & Kolbe LLP

Schubert Jonckheer & Kolbe represents consumers in class actions against corporate defendants, as well as shareholders in derivative actions against officers and directors. The firm is based in San Francisco and, with the help of co-counsel, litigates cases nationwide.

Contact
Dustin L. Schubert
dschubert@schubertlawfirm.com
Tel: 415-788-4220

Cision View original content:https://www.prnewswire.com/news-releases/genedx-holdings-corp-nasdaq-wgs-investor-alert-schubert-jonckheer-investigates-possible-false-statements-and-insider-trading-302509365.html

SOURCE Schubert Jonckheer & Kolbe LLP


Für dich aus unserer Redaktion zusammengestellt

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend